Publication:
Long-Term Effect of Interferon Therapy in Patients with HBeAg Positive Chronic Hepatitis B Infection

dc.contributor.authorSenturk, HAKAN
dc.contributor.authorBaysal, Birol
dc.contributor.authorTahan, Veysel
dc.contributor.authorZerdali, Hasan
dc.contributor.authorOzaras, Resat
dc.contributor.authorTabak, Fehmi
dc.contributor.authorMert, Ali
dc.contributor.authorCanbakan, Billur
dc.contributor.authorTabak, Omur
dc.contributor.authorOzbay, Gulsen
dc.contributor.institutionauthorŞENTÜRK, HAKAN
dc.date.accessioned2021-01-19T20:59:57Z
dc.date.available2021-01-19T20:59:57Z
dc.date.issued2011-01-01T00:00:00Z
dc.description.abstractIntroduction Several studies have reported that interferon therapy increases elimination rate of HBeAg and anti-HBe seroconversion in chronic hepatitis B (CHB) patients. We aimed to evaluate long-term results of interferon-alpha treatment in HBeAg positive CHB patients in a country with exclusively D genotype.
dc.identifier.citationSenturk H., Baysal B., Tahan V., Zerdali H., Ozaras R., Tabak F., Mert A., Canbakan B., Tabak O., Ozbay G., -Long-Term Effect of Interferon Therapy in Patients with HBeAg Positive Chronic Hepatitis B Infection-, DIGESTIVE DISEASES AND SCIENCES, cilt.56, ss.208-212, 2011
dc.identifier.doi10.1007/s10620-010-1255-9
dc.identifier.scopus79151475101
dc.identifier.urihttp://hdl.handle.net/20.500.12645/28016
dc.identifier.wosWOS:000286005900028
dc.titleLong-Term Effect of Interferon Therapy in Patients with HBeAg Positive Chronic Hepatitis B Infection
dc.typeArticle
dspace.entity.typePublication
local.avesis.id89fda022-1af1-4440-bb9f-60920c592de2
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublication278fcf63-3b92-4368-bff6-f140ebd9aeb3
relation.isAuthorOfPublication.latestForDiscovery278fcf63-3b92-4368-bff6-f140ebd9aeb3
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c
Files
Collections